Anti-thymocyte globulin triggers TNF-dependent cell death in T-cell acute lymphoblastic leukemia
Year: 2026
Type: article
Abstract: T-cell acute lymphoblastic leukemia (T-ALL) accounts for one of the most aggressive hematological tumors associated with poor prognosis, notably for relapsed and refractory patients. Hence, an unmet medical need persists for T-ALL patients who fail to durably respond to conventional treatments. Herein, we report the antileukemic efficacy of anti-thymocyte globulin (ATG), a polyclonal cocktail of IgG enriched in antibodies directed against human thymocyte antigens. The treatment of preclinical models of T-ALL reveals a cytotoxic mechanism of ATG mediated by TNFα signaling. We demonstrate that ATG resistance may occur via the induction of negative regulators of TNFα-induced cell death and can be circumvented by SMAC mimetic birinapant ex vivo and in vivo. These results are validated in a series of prospective primary relapsed/refractory T-ALL samples. Here, we provide a strong rationale for clinically relevant ATG-based immunotherapy in combination with birinapant to treat T-ALL patients. Anti-thymocyte globulin (ATG) is a potent immunosuppressant used to prevent and treat acute organ transplant rejection and severe aplastic anemia. Here, the authors discover that ATG can be repurposed to induce TNF-driven cell death in T cell acute lymphoblastic leukemia.
Source: Nature Communications
Authors: Marie Emilie Dourthe, Mehdi Latiri, Etienne Lengliné, Guillaume Charbonnier, Chaimae Saji, Grégoire Huré, Camille Gillet, Jérôme Doss, Aurore Touzart, Lucien Courtois, Agata Cieslak, Mathieu Simonin, Norbert Ifrah, Hervé Dombret, Olivier Hermine, Nicolas Boissel, André Baruchel, Jacques Ghysdael, Elizabeth Macintyre, Philippe Rousselot, Christine Tran Quang, Guillaume P. Andrieu, Vahid Asnafi
Institutions: Hôpital Necker-Enfants Malades, Inserm, Université Paris Cité, Institut Necker Enfants Malades, Assistance Publique – Hôpitaux de Paris, Hôpital Robert-Debré, Hôpital Saint-Louis, Hôpital Armand-Trousseau, Centre de Recherche Saint-Antoine, Université Pierre-et-Marie-Curie, Centre Hospitalier Universitaire d'Angers, Institut de recherche Saint-Louis, Institut des Maladies Génétiques Imagine, Centre National de la Recherche Scientifique, Université Paris-Saclay, Intégrité du génome, ARN et cancer, Institut Curie, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, CEA Paris-Saclay - Etablissement de Saclay, Centre Hospitalier de Versailles
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $6,990
Awards: G1641544042, G9000364098, G9000364723
OpenAlex ID: W7213636142
